Abstract:Wenwu He, 1, * Xuefeng Leng, 1, * Yanyu Yang, 2, * Lin Peng, 1 Yang Shao, 3, 4 Xue Li, 3 Yongtao Han 1 1 Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine, University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China; 2 Department of Radiology, Dalian Medical University, Dalian, Liaoning, People's Republic of China; 3 Department of Medicine, Nanjing Geneseeq Technology, Inc, Nanjing, Jiangsu, People's Republic of China; 4 School of Public Health, Nanjing Medical University, Nanjing, Jiangsu, People's Republic of China *These authors contributed equally to this work Correspondence: Yongtao Han Department of Thoracic Surgery, Sichuan Cancer Hospital & Institute, Sichuan Cancer Center, School of Medicine University of Electronic Science and Technology of China, Chengdu, Sichuan, People's Republic of China Tel +86-28-85420229 Email yongtao_han@126.com Background: Esophageal squamous cell carcinoma (ESCC) is a common malignant tumor with significant geographical variation and familial aggregation. However, the potentially different mechanisms underlying tumorigenesis in patients with ESCC with and without a family history of the disease remain unclear. In this study, the genes mutated in familial and nonfamilial ESCC were analyzed. Further, we aimed to explore the genes related to ESCC and attempt to identify potential patients in families with a history of ESCC. Methods: Next-generation sequencing technology was used to examine germline mutations and mutation profiles in 36 matched tumor-normal ESCC specimens. Additionally, tumor mutational burden (TMB) values were measured in two cohorts. Results: We identified four novel germline mutations in patients with familial ESCC, in BAX (c.121dupG: p.E41G), CDKN2A (c.374dupA: p.D125E), TP53 (c.856G>A: p.E286K), and CHEK1 (c.923+1G>A). Mutation profiles revealed that patients with and without a family history of ESCC had similar high-frequency gene mutation profiles, among which TP53 was the most commonly mutated gene. Additionally, tumor-specific mutated genes in patients with a positive family history of ESCC were APC, AKT3, DPYD, EP300, NFE2L2, PPP2R1A, RUNX1 , and VEGFA , while those in patients without a family history of ESCC were CXCR4, PIK3R2, SMARCA4 , and TTF1 . Moreover, patients with positive family history had significantly higher TMB values (7.8 ± 4.1 vs 5.0 ± 2.4, for patients with and without a family history, respectively; P = 0.038). Conclusion: Our results identified mutation profiles in patients with familial and nonfamilial ESCC, and identified germline mutations in patients with positive history. TMB values may be informative for immunotherapy approaches in familial ESCC. Keywords: esophageal squamous cell carcinoma, genetic heterogeneity, family heredity

Alterations of FHIT, BRCA2 and MLH1 Expressions in Esophageal Cancer Tissues from the Esophageal Cancer Patients with and Without Family History

Mismatch Repair Gene Mlh3 Pro844leu And Thr942ile Polymorphisms And The Susceptibility To Cervical Carcinoma And Hpv Infection: A Case-Control Study In A Chinese Population

Associations between cancer family history and esophageal cancer and precancerous lesions in high-risk areas of China

Genetic Heterogeneity of Esophageal Squamous Cell Carcinoma with Inherited Family History

Corrigendum: Genome-wide Association Study of Esophageal Squamous Cell Carcinoma in Chinese Subjects Identifies Susceptibility Loci at PLCE1 and C20orf54

Disease patterns in 95 pairs of Homozygous twins and familial history of 2323 esophageal cancer patients in a high incidence area in He'nan, China

[Allelic Loss and Down-Regulation of FHIT Gene Expression in Esophageal Squamous Cell Carcinoma].

Differences of Onset Age and Survival Rates in Esophageal Squamous Cell Carcinoma Cases with and without Family History of Upper Gastrointestinal Cancer from a High-incidence Area in North China

The Analysis for Identifying Large DNA Fragment Aberrations of MSH2 and MLH1 Genes from Familial Colorectal Cancer in China

FHIT gene alterations in esophageal cancer and ulcerative colitis (UC)

Differential cumulative risk of genetic polymorphisms in familial and non-familial esophageal squamous cell carcinoma.

Proteins Profile in Esophageal Multistage Carcinogenesis

GWAS follow-up study of esophageal squamous cell carcinoma identifies potential genetic loci associated with family history of upper gastrointestinal cancer

Screening for Hereditary Cancers in Patients with Endometrial Cancer Reveals a High Frequency of Germline Mutations in Cancer Predisposition Genes.

Alterations of MLH1 and Microsatellite Instability in Esophageal Squamous Cell Carcinomas

Clinical and genetic characteristics of Chinese hereditary nonpolyposis colorectal cancer families.

Clinicopathologic Features of Endometrial Cancer in Chinese Patients Younger Than 50 Years with a Family History of Cancer.

Genetic Alterations in Esophageal Tissues from Squamous Dysplasia to Carcinoma.

Histopathological Comparison of the Lesions at Esophagus, Gastric Cardia and Antrum on the Subjects from Linzhou, Henan and the Linzhou Migrated Subjects from Changzhi, Shanxi

Germline Mutations And Polymorphic Variants In Mmr, E-Cadherin And Myh Genes Associated With Familial Gastric Cancer In Jiangsu Of China

Family history of esophageal cancer modifies the association of serum lipids and malignant esophageal lesions: a nested case-control study from the “Endoscopic Screening for Esophageal Cancer in China” trial